Recipharm AB (RECI B):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Recipharm AB (RECI B) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7061
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Recipharm AB (Recipharm) is a contract development and manufacturing organization (CDMO) that offers manufacturing, and development and technology services. The organization’s manufacturing segment provides contract manufacturing of pharmaceuticals such as semi-solids, and oral liquids, solid dose, sterile products, besides clinical trial materials including APIs and other drugs. Recipharm’s development and technology segment offers raw material supply, formulation development and development of validated analytical methods, and among others. The organization operates in the UK, Germany, Spain, Italy, Sweden, France, and others. Recipharm is headquartered in Stockholm, Sweden.

Recipharm AB (RECI B) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Recipharm AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Recipharm AB, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Recipharm AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Recipharm AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Recipharm AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Recipharm AB, Medical Equipment, Deal Details 10
Partnerships 10
Recipharm Partners with Marchesini Group, Sea Vision and TraceLink 10
Debt Offering 11
Recipharm Raises USD116.4 Million in Private Placement of Bonds 11
Acquisition 12
Recipharm Acquires Remaining 26% Stake in Nitin Lifesciences for USD43.8 Million 12
Recipharm Acquires 74% Stake in Nitin Lifesciences for USD101 Million 13
Recipharm AB – Key Competitors 15
Recipharm AB – Key Employees 16
Recipharm AB – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 21
Strategy And Business Planning 21
May 24, 2018: Recipharm invests in Brexit preparations 21
Nov 09, 2017: Recipharm to end operations in two facilities in Sweden 22
Financial Announcements 23
Jul 25, 2018: Recipharm publishes its interim report January-June 2018 23
Feb 22, 2018: Recipharm Reports Fourth Quarter And Full Year 2017 25
Corporate Communications 27
Oct 03, 2018: Recipharm names Tobias Hagglov as Chief Financial Officer 27
May 09, 2018: Recipharm appoints new Chief Financial Officer 28
Feb 26, 2018: Recipharm: Chief Financial Officer to leave Recipharm 29
Feb 14, 2018: Recipharm Appoints President Development Services to Drive End to End Offering 30
Legal and Regulatory 31
Sep 13, 2018: Recipharm connects to European Hub for serialisation compliance 31
Product News 32
Oct 09, 2018: Recipharm releases first serialised products to Europe 32
Other Significant Developments 33
Mar 14, 2018: Recipharm completes Blow-fill-seal expansion at Kaysersberg facility 33
Oct 23, 2017: Recipharm equips Lisbon facility for US and European serialisation 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Recipharm AB, Medical Equipment, Key Facts, 2017 2
Recipharm AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Recipharm AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Recipharm AB, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Recipharm AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Recipharm AB, Deals By Market, 2012 to YTD 2018 8
Recipharm AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Recipharm Partners with Marchesini Group, Sea Vision and TraceLink 10
Recipharm Raises USD116.4 Million in Private Placement of Bonds 11
Recipharm Acquires Remaining 26% Stake in Nitin Lifesciences for USD43.8 Million 12
Recipharm Acquires 74% Stake in Nitin Lifesciences for USD101 Million 13
Recipharm AB, Key Competitors 15
Recipharm AB, Key Employees 16
Recipharm AB, Other Locations 18
Recipharm AB, Subsidiaries 18

List of Figures
Recipharm AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Recipharm AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Recipharm AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Recipharm AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Recipharm AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Recipharm AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Recipharm AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Recipharm AB, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Recipharm AB (RECI B):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fubon Bank (Hong Kong) Ltd:企業の戦略的SWOT分析
    Fubon Bank (Hong Kong) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Emory University-製薬・医療分野:企業M&A・提携分析
    Summary Emory University (Emory) is an educational service provider that offers academic degrees and programs through its arts colleges and graduate and professional schools. The university offers degree programs in the areas of business, law, medicine, nursing, public health, theology, and online c …
  • NovoCure Ltd (NVCR):企業の財務・戦略的SWOT分析
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • Pearson plc:企業の戦略・SWOT・財務情報
    Pearson plc - Strategy, SWOT and Corporate Finance Report Summary Pearson plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Sarossa plc:企業の戦略的SWOT分析
    Sarossa plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • TRC Companies Inc:電力:M&Aディール及び事業提携情報
    Summary TRC Companies Inc (TRC Companies) is a construction service provider that offers engineering, consulting and construction management. The company’s services include air quality management, power generation, power delivery engineering, integrity management, energy efficiency, coal ash managem …
  • Volta River Authority:企業の戦略的SWOT分析
    Volta River Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Industrias Penoles SAB de CV:戦略・SWOT・企業財務分析
    Industrias Penoles SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Industrias Penoles SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Fidelity National Information Services, Inc.:企業のM&A・事業提携・投資動向
    Fidelity National Information Services, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fidelity National Information Services, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, d …
  • Sime Darby Berhad (SIME):企業の財務・戦略的SWOT分析
    Sime Darby Berhad (SIME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Leukocare AG-製薬・医療分野:企業M&A・提携分析
    Summary Leukocare AG (Leukocare) is a clinical stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company offers services such as development of individual SPS formulations meeting i …
  • Bellerophon Therapeutics Inc (BLPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary product ca …
  • Sawai Pharmaceutical Co Ltd (4555):製薬・医療:M&Aディール及び事業提携情報
    Summary Sawai Pharmaceutical Co Ltd (Sawai Pharmaceutical) manufactures, sells, imports and exports ethical drugs and proprietary drugs. The company's products include cardiovascular drugs, antihyperlipidemic agents, diabetes drugs, anticancer drugs, and OTC drugs. It provides products in the form o …
  • Briscoe Group Limited (BGP):企業の財務・戦略的SWOT分析
    Briscoe Group Limited (BGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Verisk Analytics, Inc.:企業の戦略・SWOT・財務情報
    Verisk Analytics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Verisk Analytics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Moneygram International, Inc.:企業のM&A・事業提携・投資動向
    Moneygram International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Moneygram International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Vygon SA:企業の戦略的SWOT分析
    Vygon SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Radiation Monitoring Devices Inc:企業の製品パイプライン分析2018
    Summary Radiation Monitoring Devices Inc (RMD), a subsidiary of Dynasil Corporation of America, is a research and development company that provides solutions for security, medical and industrial applications. The company’s products include scintillators, APDs, cesium iodide, solid state photomultipl …
  • LegoChem Biosciences Inc (141080):企業の財務・戦略的SWOT分析
    Summary LegoChem Biosciences Inc (LCB) is a bio pharmaceutical company that develops next generation novel therapeutics. The company utilizes its proprietary medicinal drug discovery technology LegoChemistry and ADC platform technology ConjuAll. It manufactures drugs in the therapeutic areas of anti …
  • Alpine Immune Sciences Inc (NVLS):企業の財務・戦略的SWOT分析
    Summary Alpine Immune Sciences Inc (Alpine), formerly Nivalis Therapeutics Inc, is a pharmaceutical company that discovering and developing innovative, protein-based immunotherapies, immune synapse to treat cancer and autoimmune and inflammatory diseases. The has two products in the clinic for infla …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆